The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dual targeting of VEGF and PD-1: A phase I/II trial of ivonescimab, a novel bispecific antibody, in recurrent glioblastoma.
 
Anuj Patel
Research Funding - Summit Therapeutics
 
Ashley Aaroe
(OPTIONAL) Uncompensated Relationships - Regeneron
 
Carlos Kamiya-Matsuoka
No Relationships to Disclose
 
Ruitao Lin
Consulting or Advisory Role - ITM Oncologics; Lilly; Merck Sharp & Dohme, LLC; Monte Rosa Therapeutics
 
Nazanin Majd
Consulting or Advisory Role - Baxter (I); Celularity; Sumitomo Dainippon Pharma Co., Ltd. Consulting
Research Funding - BioMed Valley Discoveries (Inst); EMD Serono (Inst); Nerviano Medical Sciences (Inst); Novartis (Inst)
 
Barbara O'Brien
Consulting or Advisory Role - Plus Therapeutics
Research Funding - EMD Serono (Inst); Kintara Therapeutics (Inst)
 
Chirag Patel
Honoraria - College of American Pathologists; Research to Practice
Consulting or Advisory Role - Novocure
Research Funding - Novocure (Inst)
Patents, Royalties, Other Intellectual Property - Patent application with Novocure, Ltd.
Travel, Accommodations, Expenses - Novocure
(OPTIONAL) Uncompensated Relationships - BMC Neuroscience; National Brain Tumor Registry of China (NBTRC)
 
Shiao-Pei Weathers
Research Funding - Exelixis; Genentech/Roche (Inst); Mundipharma (Inst)
 
Vinay Puduvalli
Stock and Other Ownership Interests - Gilead Sciences
Honoraria - Bayer; Boehringer Ingelheim; Guidepoint Inc; InSightec; MD HealthGroup; Novocure; Orbus Therapeutics; SERVIER; Tango Therapeutics; Telix Pharmaceuticals
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Guidepoint Inc; InSightec; Newave Pharmaceutical (I); Novocure; Orbus Therapeutics; SERVIER; Tango Therapeutics; Telix Pharmaceuticals
Research Funding - Bexion; InSightec; Karyopharm Therapeutics; Kazia Therapeutics; Merck; Philogen; Radiomedix; Samus Therapeutics; SERVIER